PHILODATA signed a MOU with Philosys and PHC

PHILODATA has officially signed a MOU with global healthcare companies PHC Co., Ltd. and Philosys Co., Ltd. for personal health information data collection and platform operation.

PHC Co., Ltd. which signed this MOU, is a comprehensive healthcare company listed on the KOSDAQ. PHC has developed an application that can collect health information through various medical devices and is providing it to the world, accumulating approximately 3 million blood glucose data per year.

In addition, Philosys Co., Ltd. has agreed to provide health information, such as blood glucose measurement records obtained through the self-developed blood glucose meter and strip, to the PHILODATA platform based on this partnership. Accordingly, we plan to build a global health data collection infrastructure through MDSAP (Medical Device Single Audit Program) certification and licenses from 69 countries.

In-hwan Choi, CEO of PHC Co., Ltd. said, “Through this partnership, we hope that PHILODATA will strengthen the collection of lifelog supplies based on personal health information data and solve missions for technology commercialization.”

In addition, In Lee, CEO of Philosys Co., Ltd. said, “We want to transparently enhance the vast amount of data for the expansion of the PHILODATA platform through the healthcare devices of Philosys, which are actively exported around the world.”

Thank you.
PHILODATA Team